Mark Corrigan
Director at Wave Life Sciences Ltd. (WVE)
Mark Corrigan has filed 12 insider reports with the SEC since July 2021, as director at Wave Life Sciences Ltd. (WVE), director at Trevena Inc (TRVN) and director at Nabriva Therapeutics plc (NBRV). In the last 12 months Mark Corrigan sold $217K of stock on the open market. In the latest filing, on December 11, 2025, Mark Corrigan sold 16,115 shares of Wave Life Sciences Ltd. (WVE) for $217K at an average of $13.48.
- Filings
- 12
- Companies
- 3
- Bought on market
- None
- Sold on market
- $219K
Companies where Mark Corrigan is an insider
| Company | Role | Shares held | Bought | Sold | Avg buy | Price now | Last filing |
|---|---|---|---|---|---|---|---|
| Director | 28,815 | $217K | $2.56 | Dec 11, 2025 | |||
| Directorsince July 2023 | Jun 14, 2024 | ||||||
| Director | 7,203 | $1,956 | Aug 4, 2022 |
Shares held: common shares owned directly after the latest filing that states it. Avg buy: open-market purchase dollars divided by shares bought, every filing on record.
Every filing
- Dec 8, 2025-$217KWVEDirector Corrigan Mark sold $217,297 worth of Ordinary Shares (16,115 units at $13.48), decreasing direct ownership by 36% to 28,815 unitsForm 4Open-market sale10b5-1 plan
- Dec 8, 2025~$121KWVEMark Corrigan plans to sell 16,115 shares (~$121K)Form 144Planned sale10b5-1 plan
- Aug 11, 2025WVEDirector Corrigan Mark was granted 12,700 units of Ordinary Shares, increasing direct ownership by 39% to 44,930 unitsForm 4Grant or award
- Aug 12, 2024WVEDirector Corrigan Mark was granted 32,230 units of Ordinary SharesForm 4Grant or award
- Jun 13, 2024TRVNSEC Form 4 filed by Director Corrigan MarkForm 4Grant or award
- Aug 7, 2023WVESEC Form 4 filed by Corrigan MarkForm 4Grant or award
- Jul 18, 2023TRVNSEC Form 4 filed by Corrigan MarkForm 4Grant or award
- Jul 18, 2023TRVNSEC Form 3: New insider Corrigan Mark claimed no ownership of stock in the companyForm 3New insider
- Aug 15, 2022WVESEC Form 4 filed by Corrigan MarkForm 4Grant or award
- Aug 2, 2022-$1,956NBRVSEC Form 4: Corrigan Mark sold $1,956 worth of Ordinary Shares (10,297 units at $0.19), decreasing direct ownership by 59% to 7,203 unitsForm 4Open-market sale
- Aug 16, 2021WVESEC Form 4 filed by CORRIGAN MARKForm 4Grant or award
- Jul 28, 2021NBRVSEC Form 4: CORRIGAN MARK was granted 17,500 units of Ordinary SharesForm 4Grant or award
Also sits on boards with
Officers and directors who share two or more companies with Mark Corrigan.
Compare Mark Corrigan with
- Mark Corrigan vs Carrie L. Bourdow2 shared
- Mark Corrigan vs Heidi L Wagner1 shared
- Mark Corrigan vs Adrian Rawcliffe1 shared
- Mark Corrigan vs Aik Na Tan1 shared
- Mark Corrigan vs Ken Takanashi1 shared
- Mark Corrigan vs Christopher I Wright1 shared
Other insiders at the same companies
- Heidi L WagnerWVE
- Aik Na TanWVE
- Ken TakanashiWVE
- Adrian RawcliffeWVE
- Christopher I WrightWVE
- Erik IngelssonWVE
- Ra Capital Management, L.P.WVE
- Chris FrancisWVE
- Kyle MoranWVE
- Paul BolnoWVE
- Chandra VargeeseWVE
- GSK plcWVE
- Gregory L. VerdineWVE
- Christian O HenryWVE
- Katrine SuttonTRVN
Questions about Mark Corrigan
- What is Mark Corrigan's role at Wave Life Sciences Ltd.?
- Mark Corrigan reports to the SEC as director at Wave Life Sciences Ltd. (WVE), according to the latest filing on December 11, 2025. Mark Corrigan has also filed as director at Trevena Inc (TRVN) and director at Nabriva Therapeutics plc (NBRV).
- How many shares does Mark Corrigan own?
- After the latest filing that states it, Mark Corrigan directly owned 28,815 shares of Wave Life Sciences Ltd. (WVE) and 7,203 shares of Nabriva Therapeutics plc (NBRV). Shares held through trusts, funds or family members are reported separately and are not counted here.
- Has Mark Corrigan bought or sold stock recently?
- The most recent open-market sale was on December 8, 2025: sold 16,115 shares of Wave Life Sciences Ltd. (WVE) for $217K at an average of $13.48.
- How do I get alerts when Mark Corrigan files?
- Follow Mark Corrigan on Quantisnow and you get an email, and a phone notification on Plus, within minutes of each new Form 4 or Form 5, and of each Form 144 notice of a planned sale.
From SEC Forms 3, 4, 5 and 144 filed by Mark Corrigan (SEC CIK 0001250661). Totals count each trade once, skipping amendments whose original is on file, from Jul 31, 2021 on. View on SEC EDGAR · Get this as JSON